<DOC>
	<DOC>NCT01003405</DOC>
	<brief_summary>To investigate the long-term safety, efficacy and pharmacokinetics of KUC-7483 in patients with overactive bladder.</brief_summary>
	<brief_title>Long-term Safety and Efficacy of KUC-7483 in Patients With Overactive Bladder</brief_title>
	<detailed_description />
	<mesh_term>Urinary Bladder, Overactive</mesh_term>
	<mesh_term>p-Hydroxyamphetamine</mesh_term>
	<criteria>Patients who have successfully completed the Phase III doubleblind study. Patients with serious adverse events or clinically significant adverse events in the Phase III doubleblind study.</criteria>
	<gender>All</gender>
	<minimum_age>20 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>July 2010</verification_date>
	<keyword>Overactive bladder</keyword>
	<keyword>Frequency</keyword>
	<keyword>Micturition</keyword>
	<keyword>Urgency</keyword>
	<keyword>Urge urinary incontinence</keyword>
	<keyword>OAB</keyword>
</DOC>